ANTURANE(SULFINPYRAZONE) - 美国FDA药品数据库

药品名称	ANTURANE
申请号	011556	产品号	004
活性成分	SULFINPYRAZONE	市场状态	停止上市
剂型或给药途径	CAPSULE;ORAL	规格	200MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons
治疗等效代码		参比药物	否
批准日期	Approved Prior to Jan 1, 1982	申请机构	NOVARTIS PHARMACEUTICALS CORP
化学类型	New molecular entity (NME)	审评分类	Standard review drug

与本品相关的专利信息（来自橙皮书Orange Book）
专利号	专利过期日	是否化合物专利	是否产品专利	专利用途代码	专利下载
无
历史专利信息
无

药品注册审批历史信息
申请号	修订号	审批结论	审批日期	审批内容
011556	054	AP	1999/04/22	Package Change
011556	053	AP	2002/08/26	Labeling Revision
011556	052	AP	1998/09/12	Control Supplement
011556	051	AP	1993/01/04	Control Supplement
011556	050	AP	1992/10/20	Formulation Revision
011556	049	AP	1990/06/13	Formulation Revision
011556	048	AP	1987/07/08	Formulation Revision
011556	047	AP	1986/09/02	Manufacturing Change or Addition
011556	046	AP	1987/03/17	Manufacturing Change or Addition
011556	045	AP	1986/04/07	Labeling Revision
011556	044	AP	1986/12/08	Manufacturing Change or Addition
011556	043	AP	1985/09/30	Control Supplement
011556	042	AP	1985/02/27	Control Supplement
011556	041	AP	1985/10/08	Control Supplement
011556	040	AP	1983/04/09	Package Change
011556	038	AP	1984/06/12	Labeling Revision
011556	037	AP	1980/02/26	Manufacturing Change or Addition
011556	036	AP	1980/10/27	Control Supplement
011556	035	AP	1979/09/07	Manufacturing Change or Addition
011556	034	AP	1979/07/20	Manufacturing Change or Addition
011556	033	AP	1979/07/20	Manufacturing Change or Addition
011556	032	AP	1978/08/29	Expiration Date Change
011556	031	AP	1978/09/26	Control Supplement
011556	000	AP	1959/05/13	Approval